Merck & Co. Inc. buy Royal Bank of Canada
Start price
25.02.26
/
50%
€105.40
Target price
25.02.27
€120.47
Performance (%)
-9.74%
Price
20:04
€95.13
Summary
This prediction is currently active. With a performance of -9.74%, the BUY prediction by Royal_Bank_of_Canada is trending in the wrong direction. This prediction currently runs until 25.02.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Merck & Co. Inc. | 2.859% | 2.859% |
| iShares Core DAX® | 0,42 % | 5,71 % |
| iShares Nasdaq 100 | 4,10 % | 16,64 % |
| iShares Nikkei 225® | 4,47 % | 18,34 % |
| iShares S&P 500 | 1,79 % | 9,64 % |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Merck & Co. Inc. diskutieren
Merck & Co., Inc. (MRK) is now covered by Royal Bank Of Canada. They set an "outperform" rating and a $142.00 price target on the stock.
Ratings data for MRK provided by MarketBeat